Jeff Prusakiewicz

Jeff Prusakiewicz is an experienced professional in drug metabolism and pharmacokinetics (DMPK) chemistry, currently serving as Associate Director of DMPK Chemistry at Arrowhead Pharmaceuticals since February 2019. Prior to this role, Jeff worked at Covance as a Senior Study Director, overseeing DMPK and PK/PD aspects of IND enabling programs, and held positions at Pfizer as a Principal Scientist and Senior Scientist, focusing on DMPK activities in preclinical development. Jeff's career also includes significant contributions to GLP study conduct and experimental design while at Covance Laboratories. Educational qualifications include a PhD in Biochemistry from Vanderbilt University and a BS in Biochemistry from Oakland University.